RAMUCIRUMAB - Food and Drug Administration
- Set ID
- 4c83d4ea-a6ad-4aca-a3ad-8ee32b69724a
- Type
- Indexing - product concept
- Effective date
- 2019-08-06
- Version
- 1
- Source
- DailyMed source
Mapped DailyMed Labels#
| Label | Relation | Manufacturer | Effective |
|---|---|---|---|
| These highlights do not include all the information needed to use CYRAMZA safely and effectively. See full prescribing information for CYRAMZA. CYRAMZA (ramucirumab) injection, for intravenous use Initial U.S. Approval: 2014 | Product name | Eli Lilly and Company | 2026-06-09 |
| These highlights do not include all the information needed to use CYRAMZA safely and effectively. See full prescribing information for CYRAMZA. CYRAMZA (ramucirumab) injection, for intravenous use Initial U.S. Approval: 2014 | Product name | Eli Lilly and Company | 2025-12-18 |
| These highlights do not include all the information needed to use CYRAMZA safely and effectively. See full prescribing information for CYRAMZA. CYRAMZA (ramucirumab) injection, for intravenous use Initial U.S. Approval: 2014 | Product name | Eli Lilly and Company | 2025-08-19 |